ACAT1 and non-small cell lung carcinoma: If the presence of high sterol ester subtype of NSCLC can be confirmed, ACAT1 becomes a promising therapeutic target given that inhibition of ACAT1 has been shown to cause apoptosis in pancreatic cancer via a buildup of intracellular cholesterol and increased endoplasmic reticulum stress [68].